Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up
JNCI Cancer Spectrum · 03.03.2026 · 10 (2)
DOI: 10.1093/jncics/pkag028 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 17.03.2026. Verfasst von Kathleen Van Dyk und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los An…. Hauptthemen laut MEDLINE: Breast Neoplasms, Apolipoprotein E4, Cognition, Antineoplastic Agents, Hormonal. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, Georgetown Lombardi Comprehensive Cancer Center for support of the Biostatistics and Bioinformatics Resource and the Non-Therapeutic Shared Resource.
Abstract (Originalsprache)
Cognitive effects of breast cancer antiestrogen endocrine therapy are a salient concern for survivors, given the growing evidence that estrogen plays a role in late-life dementia risk. The APOE4 genotype has been linked with risk for cognitive difficulties, studied mainly in younger cancer survivors. We found that women aged 60+ with nonmetastatic breast cancer enrolled in the prospective Thinking and Living with Cancer study who underwent endocrine therapy had lower subjective (P = .06) and objective (P = .08) cognitive function than frequency-matched controls across time. At 5 years, however, women with breast cancer exposed to endocrine therapy and APOE4 carriers in particular exhibited lower learning and memory scores than other groups (P < .05). Our results suggest endocrine therapy may have long-term effects on cognitive function in women with breast cancer, particularly APOE4 carriers. Further characterization of genetic risk for long-term cognitive decline will be useful to inform survivorship care of older women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United States.
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.
- City of Hope, Duarte, CA, United States.
- Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, United States.
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
- Department of Exercise Science and Health Promotion, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, FL, United States.
ORCID-Profile: Kathleen Van Dyk, Tim A Ahles, James C Root, Jaeil Ahn, Ashley L Artese, Traci N Bethea, Martine Extermann, Deena Graham, Claudine Isaacs, Heather S L Jim, Brenna C McDonald, Zev M Nakamura, Sunita K Patel, Kelly E Rentscher, Andrew J Saykin, Brent J Small, Danielle B Tometich, Xingtao Zhou, Judith E Carroll, Jeanne S Mandelblatt
Förderung
- NIA NIH HHS
- NCI NIH HHS
- Georgetown Lombardi Comprehensive Cancer Center for support of the Biostatistics and Bioinformatics Resource and the Non-Therapeutic Shared Resource
- National Cancer Institute at the National Institutes of Health
- Frank M. Ewing Foundation Endowed Chair of Hematology and Oncology
- Thinking and Living cohort
- National Institute on Aging
Zitieren
APA
Van Dyk, K., Zhai, W., Ahles, T. A., Root, J. C., Ahn, J., Artese, A. L., Bethea, T. N., Cohen, H. J., Extermann, M., Graham, D., Isaacs, C., Jim, H. S. L., McDonald, B. C., Nakamura, Z. M., Patel, S. K., Rentscher, K. E., Saykin, A. J., Small, B. J., Tometich, D. B., …, & Mandelblatt, J. S. (2026). Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up. JNCI Cancer Spectrum, 10(2). https://doi.org/10.1093/jncics/pkag028
Vancouver
Van Dyk K, Zhai W, Ahles TA, Root JC, Ahn J, Artese AL, et al. Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up. JNCI Cancer Spectrum. 2026;10(2). doi:10.1093/jncics/pkag028
BibTeX
@article{VanDyk2026,
author = {Van Dyk, Kathleen and Zhai, Wanting and Ahles, Tim A and Root, James C and Ahn, Jaeil and Artese, Ashley L and Bethea, Traci N and Cohen, Harvey J and Extermann, Martine and Graham, Deena and Isaacs, Claudine and Jim, Heather S L and McDonald, Brenna C and Nakamura, Zev M and Patel, Sunita K and Rentscher, Kelly E and Saykin, Andrew J and Small, Brent J and Tometich, Danielle B and Zhou, Xingtao and Carroll, Judith E and Mandelblatt, Jeanne S},
title = {Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up},
journal = {JNCI Cancer Spectrum},
year = {2026},
volume = {10},
number = {2},
doi = {10.1093/jncics/pkag028}
}
EUVIMED